Pathnostics is a global diagnostics solutions company specializing in key therapeutic areas, including urology, women’s health, gastroenterology and cancer. The company has grown rapidly in recent years as increasing numbers of specialists have adopted its Guidance test, the only test to simultaneously diagnose and guide antibiotic treatment in rapid turnaround time for complex, recurring urinary tract infections. Studies show that Pathnostics’ proprietary technology has strong potential to reduce hospitalizations and improve patient satisfaction – a significant need and priority across the healthcare industry. Water Street partnered with Pathnostics in 2019 to leverage our diagnostics expertise and network of resources to expand Pathnostics’ innovative technology and solutions into new therapeutic areas, as well as in current markets.
Chief Executive OfficerWork with us
Dave Pauluzzi is the co-founder and chief executive officer of Pathnostics, a diagnostic solutions company. He has a strong track record of building and growing premier diagnostic and healthcare services businesses during a distinguished career spanning nearly 30 years in healthcare. These included publicly traded corporations, and start-up or mid-sized companies backed by private equity or venture capital firms. Prior to co-founding Pathnostics, Dave was president and CEO of PLUS Diagnostics (now Inform Diagnostics), which he partnered with Water Street to grow from a regional laboratory into a national anatomic pathology leader. He also served as executive director and vice president of Quest Diagnostics, the world’s leading provider of diagnostic information services, and vice president of sales and marketing/COO for US Labs. Dave also held positions in sales and marketing for Ventana Medical Systems (now Roche Diagnostics), a medical device and reagent business. Dave began his career with Abbott Laboratories, spending nine years in various roles in the company’s diagnostics division. He received his bachelor’s degree in public accounting from Loyola University of Chicago and is a member of the CEO Roundtable at the University of California-Irvine.